Treatments for asthma include reliever inhalers, long-term inhalers, and pills—and in many cases, these are enough to keep ...

Scientists at deCODE genetics have uncovered a rare genetic variant in the STAT6 gene that protects against asthma, a ...

USA: Recent findings published in The Journal of Allergy and Clinical Immunology highlight the potential for long-term ...

Discover a study that shows that modulating STAT6 directly may represent an innovative strategy for managing severe, ...

Using single maintenance and reliever therapy (SMART) is cost‐effective vs ICS/LABA maintenance plus SABA reliever in uncontrolled asthma.

At the recent American College of Allergy, Asthma & Immunology (ACAAI) annual meeting, experts discussed the evolving concept ...

Collaborative efforts in R&D are also vital for driving innovation in asthma treatments. DelveInsight's severe asthma pipeline report depicts a robust space with 40+ active players working to ...

A key driver in the market’s expansion is the segment addressing severe asthma with fungal sensitization (SAFS), which is ...

Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...

Over 40 companies are working on more than 50 therapies for severe asthma. The severe asthma market is growing due to a rising number of cases, particularly in urban areas and advancements in ...

Although COPD and asthma share similarities, recognising their differences is essential for accurate diagnosis and treatment.

Researchers at National Jewish Health and colleagues have identified a mechanism involved in the formation of mucus plugs in ...